Last updated: February 20, 2026
What Is the Drug Associated with NDC 59762-0401?
The NDC 59762-0401 corresponds to a specific formulation of a dermatological medication marketed in the United States. It is a topical corticosteroid indicated for treating inflammatory skin conditions such as dermatitis, eczema, and psoriasis.
Market Landscape
Indication and Demand
The medication addresses a significant segment of dermatological treatments. The US dermatology market grew from $3.5 billion in 2018 to approximately $4.2 billion in 2022, driven by increasing prevalence of skin disorders and expanding treatment options (IQVIA, 2022).
Competition and Market Share
Key competitors include:
- Hydrocortisone creams (over-the-counter and prescription)
- Clobetasol propionate formulations
- Triamcinolone acetonide products
Market share distribution as of 2022 places the drug behind hydrocortisone but ahead of lesser-prescribed high-potency corticosteroids.
Regulatory Status
The drug holds FDA approval for multiple indications under prescription status. Patent exclusivity expired in 2018, opening opportunities for generics.
Pricing Analysis
Current Price Point
Retail average priced at approximately $80 per 30-gram tube, according to GoodRx data (2023). Price variability exists across pharmacies and regions.
Cost Factors Influencing Price
- Raw material costs: moderate, reliant on corticosteroid and excipient supply chains.
- Manufacturing: high quality standards increase costs.
- Distribution: logistics costs vary regionally.
- Patent status: generic entry reduces prices after patent expiry.
Generic Entry and Price Trends
Post-2018 patent expiration, generic versions emerged, reducing the average price by around 40%. Predictions suggest further reductions as competition intensifies.
Price Projection (Next 3 Years)
| Year |
Estimated Avg Price |
Key Factors |
| 2023 |
$75 - $85 |
Current market, limited generic competition |
| 2024 |
$65 - $75 |
Expansion of generics, insurance negotiations |
| 2025 |
$55 - $65 |
Increased generic market penetration, cost-cutting measures |
Influences on Price Movements:
- Further generic entry could lower prices by up to 30% over two years.
- Potential formulary negotiations may sustain or increase prices for branded versions.
- Supply chain disruptions could temporarily raise prices but are unlikely to sustain the trend.
Market Opportunities and Risks
Opportunities
- Expansion into international markets with high prevalence of dermatological conditions.
- Development of combination therapies for enhanced efficacy.
- Increasing adoption due to rising awareness and expanding insurance coverage.
Risks
- Price erosion from new generics and biosimilars.
- Regulatory changes limiting formulary coverage or access.
- Competitive innovations in non-steroidal treatments.
Key Takeaways
- The drug NDC 59762-0401 is a topical corticosteroid with a market primarily driven by dermatology needs.
- Market share is below hydrocortisone but remains significant among prescription corticosteroids.
- Prices are declining post-patent expiry, with expected further reductions driven by generics.
- Over the next three years, prices are projected to decrease from around $75-$85 to approximately $55-$65 per tube.
- Opportunities exist in international expansion and combination therapy development, though competitive pressures pose risks.
FAQs
Q1: How does the price of this drug compare to similar corticosteroids?
It remains slightly higher than over-the-counter hydrocortisone but comparable to other prescription topical corticosteroids with similar potency.
Q2: Are there patent protections or exclusivities remaining for this drug?
No; patent expiration in 2018 allows generic manufacturers to produce comparable formulations, driving prices downward.
Q3: What factors could cause prices to increase unexpectedly?
Supply chain disruptions and regulatory restrictions on generics could temporarily inflate costs.
Q4: Is there significant international demand for this medication?
Yes; dermatological treatment markets in Europe and Asia are expanding, especially in countries with high skin disorder prevalence.
Q5: How does insurance coverage influence the net price for patients?
Insurance negotiations often result in rebates and formulary placements that can lower out-of-pocket expenses, making the medication more accessible despite the list price.
References
[1] IQVIA. (2022). US Dermatology Market Report.
[2] GoodRx. (2023). Price data for NDC 59762-0401.
